- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/16 - BenzazepinesHydrogenated benzazepines
Patent holdings for IPC class C07D 223/16
Total number of patents in this class: 403
10-year publication summary
|
27
|
24
|
34
|
19
|
21
|
22
|
20
|
14
|
20
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Arena Pharmaceuticals, Inc. | 353 |
26 |
| Les Laboratoires Servier | 502 |
22 |
| Hoffmann-La Roche Inc. | 3699 |
11 |
| Bolt Biotherapeutics, Inc. | 121 |
11 |
| Array BioPharma Inc. | 458 |
9 |
| Otsuka Pharmaceutical Co., Ltd. | 1502 |
9 |
| Shanghai Zhimeng Biopharma Inc. | 34 |
9 |
| Cadila Healthcare Limited | 300 |
7 |
| Chengdu Anticancer Bioscience Ltd | 23 |
7 |
| F. Hoffmann-La Roche AG | 7837 |
6 |
| Boehringer Ingelheim International GmbH | 4509 |
6 |
| Board of Regents, The University of Texas System | 6050 |
6 |
| Takeda Pharmaceutical Company Limited | 2718 |
6 |
| VentiRx Pharmaceuticals, Inc. | 16 |
6 |
| The Regents of the University of California | 20574 |
5 |
| Lek Pharmaceuticals d.d. | 189 |
5 |
| Shanghai de Novo PharmaTech Co Ltd. | 33 |
5 |
| Urquima, S.A. | 9 |
5 |
| Astellas Pharma Inc. | 1030 |
4 |
| Denali Therapeutics Inc. | 261 |
4 |
| Other owners | 234 |